top of page
Browse by category
Search


Weight loss drugs and surgery improve fat-to-muscle ratio in obesity
Both the new weight loss drugs and bariatric surgery improve body composition in patients with obesity by inducing a moderate loss of fat-free mass (including lean muscle) along with a substantial reduction in fat, researchers at Vanderbilt Health have found. Weight loss study team: From left, Danxia Yu, PhD, Zicheng Wang, MS, Lei Wang, PhD, and Jason Samuels, MD, are co-authors of a paper evaluating body composition changes after bariatric surgery or treatment with the new w


Lack of support for people on weight loss drugs leaves them vulnerable to nutritional deficiencies
People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficiencies and muscle loss, according to University College London (UCL) and University of Cambridge researchers. The research led by Dr Marie Spreckley from the University of Cambridge, found a lack of robust evidence surrounding nutritional advice and support and the impact this has on


Imaging reveals how weight loss drugs target the brain and pancreas
An international research team from Leibniz-FMP, the University of Oxford and the University of Birmingham have developed a novel imaging...


FDA approves Lilly's Zepbound (tirzepatide) for chronic weight management
The FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that...


STEP TEENS trial: Semaglutide in adolescents reduces weight and improves liver health
Two new secondary analyses of the STEP TEENS trial presented at this year's European Congress on Obesity have reported that almost half...


ECRI report identifies reasons weight loss drugs have been underutilised
ECRI, the largest non-profit patient safety organisation in the US, is calling on healthcare leaders to change their approach and fully...


Triptan migraine drugs may be effective in treating obesity
Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a study by scientists at UT Southwestern...


FDA approves Phase II trial for obesity-treating drug pemvidutide
The Food and Drug Administration (FDA) has approved a Phase II clinical trial for investigational obesity-treating drug pemvidutide. The...


AstraZeneca and Regeneron to develop obesity treatments
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed...


EBWMP plus anti-obesity medications results in greater weight loss
A Cleveland Clinic study has reported that adults with obesity lost significantly more weight when they had access to medications for...
Browse by tag






bottom of page

